Cargando…
Over-expression of RALYL suppresses the progression of ovarian clear cell carcinoma through inhibiting MAPK and CDH1 signaling pathways
Background: The molecular mechanism in the progression of ovarian clear cell carcinoma (OCCC) remains unclear. Objective: This study aimed to investigate the potential function of RAYLY in OCCC. Methods: To validate RAYLY expression, immunohistochemistry, quantitative real-time PCR and western blott...
Autores principales: | Xia, Ye, Ye, Shanting, Yang, Yang, Liu, Yuchen, Tong, Guoqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797558/ https://www.ncbi.nlm.nih.gov/pubmed/33437214 http://dx.doi.org/10.7150/ijms.51488 |
Ejemplares similares
-
Exploring the role of RALYL in Alzheimer’s disease reserve by network-based approaches
por: Zhang, Yixuan, et al.
Publicado: (2020) -
RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-β2
por: Wang, Xia, et al.
Publicado: (2021) -
Review the progression of ovarian clear cell carcinoma from the perspective of genomics and epigenomics
por: Tong, An, et al.
Publicado: (2023) -
Cyclovirobuxine inhibits the progression of clear cell renal cell carcinoma by suppressing the IGFBP3-AKT/STAT3/MAPK-Snail signalling pathway
por: Liu, Yadong, et al.
Publicado: (2021) -
A novel protein encoded by circMAPK1 inhibits progression of gastric cancer by suppressing activation of MAPK signaling
por: Jiang, Tianlu, et al.
Publicado: (2021)